Dissertation > Excellent graduate degree dissertation topics show

Effects ofβ3-adrenoceptor Activation on the Atherosclerosis

Author: WangZhaoHong
Tutor: LiYanFang
School: Capital University of Medical Sciences
Course: Internal Medicine
Keywords: β3-adrenoceptor agonist antagonist apolipoprotein E-deficient mouse atherosclerosis
CLC: R543.5
Type: PhD thesis
Year: 2013
Downloads: 17
Quote: 0
Read: Download Dissertation

Abstract


BackgroundAtherosclerotic （AS） disease is the leading cause of morbidity and mortality inthe western world and developing countries. It is associated with a metabolic andvascular cluster of disorders. The major risk factors of atherosclerosis includehyperlipidemia, glucose intolerance, hypertension, smoking and aging.Hyperlipidemia is summarized as raised trigIyceride （TG）, total cholesterol （TC） andlow density lipoprotein-cholesteroI （LDL-C） levels, reduced （high densitylipoprotein-cholesteroI） HDL-C level. Studies indicate that reducing LDL-C levelsand/or increasing HDL-C levels can decrease efficiently the incidence of AS disease.Recently, the epidemiology showed that the single standard of LDL-C level can onlyreduce the30%to45%of major coronary events. AS the raised LDL-C level, thereduced HDL-C levels also have high cardiovascular event risk. The increase ofHDL-C level with every1%would reduce the incidence of cardiovascular eventswith2%to3%. HDL involves in reverse cholesterol transport （RCT） which HDLinhibites the aggregation of cholesteryl ester in macrophages and prevents theformation of foam cells in the plaque. In addition, HDL also has anti-inflammatory,antioxidant, anticoagulant and improves the endothelial function. In recent years, thenew medcines are actively developed which could elevated HDL levels and enhanceits functionality.As the most important anti—atherosclerotic mechanism in vivo RCT，is aprocess which dynamically transport of excess cholesterol from the periphery into theliver, followed by excretion in the feces or the bile．Scavenger receptor class B type I （SR-BI） had already proved in molecular level as the sole HDL receptor whichlocates on celluar membrane．As the HDL specific receptor, SR-BI plays an importantrole in the HDL metabolism and the process of RCT. Apolipoprotein A-I （ApoA-I） isthe basic structure area of HDL combinated with SR-B1. It is essential that theappropriate position and content of ApoA-I in order to work effectively in the processof RCT. In addition, peroxisome proliferator-activated receptors （PPARs） recently areone of the main mechanisms of anti-atherosclerotic. PPARs belong to the members ofthe nuclear receptor superfamily including PPARα, PPARβand PPARγ. PPARαregulates fatty acid metabolism. PPARγ involve in lipid metabolism, glucosemetabolism and inflammation process by affecting fat cells differentiation andstorage.Thus PPARs interfere with the development of atherosclerosis.During the1980s, the classification of β-adrenoceptor （β-AR） was modifiedfollowing the discovery of a third β-AR primarily in rat adipose tissue. β3-ARmediates the major effects of adrenaline and noradrenaline in adipose tissues, such aslipolysis in white adipose tissue and thermogenesis in brown adipose tissue. Itbelongs to the G-protein coupled receptor family which involves the activation ofadenylyl cyclase, cAMP/protein kinase A （PKA） pathway and recruits a PI3-kinasepathway. Previous studies have shown that chronic treatments of β3-AR agonists wereeffective in improving glycaemic control, insulin sensitivity and reducing plasma TG,free fatty acid levels and body weight in obese diabetic animals. However the effectsof β3-AR on atherosclerosis disease are largely unknown.ObjectiveTo study the effects of β3-adrenoceptor （β3-AR） activation on lipid, glucosemetabolism, the β3-AR mRNAexpressions in withe adipose tissue, ApoA-I, ApoA-II,SR-BI expressions in liver tissue and atherosclerotic plaque development in agedapolipoprotein E-deficient (ApoE-/-) mice. The study discussed β3-AR possible mechanisms and provided the evidenceand which its function of HDL metabolism，the RCT process and atherosderosis．MethodsTen10-week-old wild-type C57BL/6J mice （A group） were fed normal chow.Fifty10-week-old ApoE-/-mice were fed high-fat diet. At36-week-old, ApoE-/-micewere randomly given normal saline （B group）, atorvastatin （10mg kg-1d-1, C group）,β3-AR agonist BRL37344（1.65μg kg-1, twice a week, D group）, BRL37344（3.30μg kg-1, twice a week, E group） and β3-AR antagonist SR52390A （50μg kg-1,twice a week, F group） for12weeks. The serum lipid, glucose and insulin levels weremeasured. The protein expressions of ApoA-I, SR-BI in the liver tissue by westernblot．Real-time quantitative PCR was used to determine the expressions of ApoA-ImRNA, ApoA-II mRNA, SR-BI mRNAand PPARα mRNA in the liver tissue and theexpression of β3-AR mRNA and PPARγ mRNA in withe adipose tissue of mice. Theatherosclerotic plaque area in the thoracic aortic was determined withHematoxy-Eosin stain, and level of fibrosis in the plaque was assessed with Massonstain.Results1. Compared with wild-type C57BL/6J mice, ApoE-/-mice showed a significanthyperlipidemia, insulin résistance, the downregulation expression of β3-AR mRNAand SR-BI （P <0.01）, the upregulation expression of ApoA-I, ApoA-II and PPARαmRNA （P <0.01）, PPARγ mRNA levels in adipose tissue was no significant changes（P＞0.05）, atherosclerotic plaque formation with obvious fibrosis in the thoracicaortic （P <0.01）.2. Compared withApoE-/-control mice with saline, atorvastatin obviouslydecreased the serum levels ofTC, VLDL/LDL-C, HDL-C and Ins （P <0.01）, but hadno effect on TG and Glu （P＞0.05）. In additionally, atorvastatin significiantly upregulated the expression ofApoA-I, ApoA–II, SR-BI and PPARα in liver tissueand the expression of PPARγ mRNA in adipose tissue （P <0.01）. β3-AR mRNAlevelsof adipose tissue did not change significantly （P>0.05）.Atorvastatin could decreasethe atherosclerotic plaque size （P <0.01）.3. Compared with ApoE-/-control mice with saline, low or high dose β3-ARagonist significantly decreased the serum levels of TG, Glu and Ins, and obviouslyelevated HDL-C level and HDL-C/TC ratio. Simultaneously, β3-AR agonist coulddistinctly up-regulate β3-AR mRNA, ApoA-I and SR-BI levels, down-regulateApoA-II and PPARα mRNA levels and decrease the atherosclerotic plaque size（P<0.01）. PPARγ mRNA levels of adipose tissue did not change significantly （P>0.05）. Effect of high dose β3-AR agonist was significantly superior to low dose（P<0.01）.4. Compared with atorvastatin group, the effects of high dose β3-AR agonistwere similar in decreasing the atherosclerotic plaque size（P>0.05）, but high doseβ3-AR agonist was better than atorvastatin in increasing levels of HDL-C, HDL-C/TCand in reducing levels of insulin（P<0.01）. β3-AR agonist obviously up-regulated theβ3-AR expression and down-regulated the expression ofApoA-I, ApoA-II, SR-BI,PPARα and PPARγ （P<0.01）.5. Compared with ApoE-/-control mice，β3-AR antagonist had no effect on lipids、Glu、Ins and the atherosclerotic plaque size （P>0.05）. PPARγ mRNA levels wasincreased significiantly in β3-AR antagonist group（P<0.01）. There was no obviouschange about ApoA-I, ApoA-II, SR-BI, β3-AR and PPARα expression （P>0.05）. Conclusion1. β3-AR activation can improve the aged ApoE-/-mice lipid metabolism,reducing levels of TC, VLDL/LDL-C and TG，increasing level of HDL；2. β3-AR activation can improve the aged ApoE-/-mice glucose metabolism,reducing levels of glucose and insulin；3. β3-AR activation can up-regulate levels of β3-AR mRNAexpression in whiteadipose tissue, ApoA-I and SR-BI expression in the liver tissue；4. β3-AR activation can down-regulate levels of ApoA-II and PPARα mRNAexpression in the liver tissue；5. β3-AR activation had no obvious effect on PPARγ mRNA expression of theaged ApoE-/-mice；6. β3-AR activation can significantly decrease the atherosclerotic plaque sizeand play a role of anti-atherosclerosis.

Related Dissertations

  1. Serum A-FABP Levels and Its Expression in Atherosclerotic Plaques of Diabetes Mellitus,R587.1
  2. Preparition and Biological Control Effect of Microbial Organical Fertilizer Against Cotton Verticillium Wilt,S435.621
  3. The Changes of Intimal Macrophages, Smooth Muscle Cells, Collagen, and Cpt-Ⅰ, GLUT-4 of Vascular Media in Human Lower Limb Artery with Atherosclerotic Stenosis,R543.5
  4. Effect of High Glucose on Chemokine Ligand 16 (CXCL16) Expression and Secretion in THP-1 Macrophages and Intervention of Aspirin in the Activity,R587.2
  5. Correlation Research of Plasma Apolipoprotein CⅢ and High Sensitive C-reactive Protein with Atherothrombotic Cerebral Infarction,R743.33
  6. Role of G31P in Smooth Muscle Migration of A7r5 Cells Induced by Interleukin-8,R363
  7. Low Dose of Spironolactone Reduces Oxidative Stress and Prevents the Development of Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus,R587.2
  8. The Crosstalk Between α-adrenoceptor Agonist Induced and Toll-like Receptor 4 Mediated Signaling Pathway,R341
  9. Carotid Artery Wall Elasticity and Carotid Atherosclerosis in Diabetes Mellitus Patients with Microalbuminuria Using Ultrasonographic Elastography and High-freguency Ultrasound,R445.1
  10. Correlative Study on Plasma Level of Resistin in Patients with Coronary Atherosclerosis Disease,R541.4
  11. Relationship Between Chronic Obstructive Pulmonary Disease and Coronary Atherosclerotic,R563.9
  12. The Relationship of Serum Adiponectin、Nitric Oxide Synthase and Carotid Atherosclerosis in Patients with Acute Cerebral Infarction,R743.33
  13. Ischemic stroke and carotid atherosclerosis and related biochemical hs-CRP and LDL-C changes,R743.3
  14. Relationship between the PAPP-A Gene Polymorphism and Ischemic Cerebrovascular Disease,R743
  15. Discovery and optimization of novel FXR antagonists and inhibitors of DHODH,R917
  16. Effects of Andrographolide on Expression and Activity of MMP-2 and MMP-9 in Macrophages,R285.5
  17. The Role of IL-32γ in Vascular Smooth Muscle Cell Proliferation,apoptosis and Secretion and Its Mechanism,R363
  18. The Study on Blocking Adrenegic Receptor and Vascular Protection of TJ0711,R544.1
  19. Effect of Rosuvastatin on IL-8 Expression of Atherosclerotic Rabbits,R543.4
  20. Change the Role and Mechanism of Macrophages Biological Functions in Atherosclerosis Regulated by Shear Stress,R543.5
  21. Sensitive Bioassay for Detection of Perfluorinated Compounds with Gold Nanoparticle Probe,R134

CLC: > Medicine, health > Internal Medicine > Heart, blood vessels ( circulatory ) disease > Vascular disease > Artery disease
© 2012 www.DissertationTopic.Net  Mobile